• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.4715 -0.0127 (-2.62%)
Streaming Delayed Price Updated: 9:56 AM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
April 16, 2026
Via ACCESS Newswire
News headline image
These stocks are moving in today's after hours session ↗
April 13, 2026
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
April 07, 2026
Via ACCESS Newswire
News headline image
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
March 30, 2026
Via ACCESS Newswire
Which stocks are moving on Wednesday? ↗
March 18, 2026
Via Chartmill
News headline image
Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans
March 04, 2026
Via ACCESS Newswire
News headline image
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
March 03, 2026
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
March 02, 2026
Via Chartmill
Top movers in Friday's after hours session ↗
February 27, 2026
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
February 27, 2026
Via Chartmill
Discover the most active stocks in Friday's session. ↗
February 27, 2026
Via Chartmill
News headline image
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL-Supported Clinical Evaluation – More Stocks Inside
February 27, 2026
Via AB Newswire
Which stocks are moving on Friday? ↗
February 27, 2026
Via Chartmill
Gapping stocks in Friday's session ↗
February 27, 2026
Via Chartmill
What's going on in today's pre-market session ↗
February 27, 2026
Via Chartmill
News headline image
Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value
February 25, 2026
Via ACCESS Newswire
News headline image
Ensysce Biosciences Invited to Participate in Upcoming Scientific and Industry Events
February 23, 2026
Via ACCESS Newswire
Unusual volume stocks are being observed in Wednesday's session. ↗
February 18, 2026
Via Chartmill
Which stocks have an unusual volume on Tuesday? ↗
February 17, 2026
Via Chartmill
Top stock movements in today's session. ↗
February 10, 2026
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
February 10, 2026
Via Chartmill
Here are the top movers in Tuesday's session. ↗
February 10, 2026
Via Chartmill
These stocks are gapping in today's session ↗
February 10, 2026
Via Chartmill
Top movers in Tuesday's pre-market session ↗
February 10, 2026
Via Chartmill
Monday's after hours session: top gainers and losers ↗
February 09, 2026
Via Chartmill
News headline image
Ensysce Biosciences Expands Global Opioid Patent Portfolio
January 21, 2026
Via ACCESS Newswire
News headline image
Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection
January 08, 2026
Via ACCESS Newswire
News headline image
Ensysce Biosciences Issues Annual Shareholder Letter
January 05, 2026
Via ACCESS Newswire
News headline image
Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid
December 09, 2025
Via ACCESS Newswire
News headline image
Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
December 02, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap